by milena henderson | Oct 16, 2025 | Non classé
On 3 October 2025, Dr Mekdes Daba, Health Minister of Ethiopia, announced a major achievement for the country: the formal recognition of the Ethiopian Food and Drug Authority (EFDA) as a Maturity Level 3 (ML3) regulatory system by the World Health Organization (WHO)....
by milena henderson | Oct 16, 2025 | Non classé, Quality & Business Excellence
In early June, Pharmalys took part in the Epicentre Scientific Day hosted at the Institut Pasteur in Paris. Representing the company, Business Development and Strategic Partnerships Associate Arthur joined researchers, NGOs, and health professionals to engage with the...
by milena henderson | Oct 16, 2025 | Non classé
Breast cancer remains the most common cancer among women worldwide. In the United States, statistics suggest that one in eight women will receive a diagnosis in her lifetime. In 2025 alone, it is estimated that 316,950 women and 2,800 men will be diagnosed with...
by milena henderson | Jun 17, 2025 | Non classé
At Pharmalys, we proudly stand alongside the global community championing health and social care research through the #Red4Research initiative. This movement honours the countless individuals, research participants, patients, healthcare professionals, volunteers, and...
by milena henderson | Jun 11, 2025 | Non classé, Quality & Business Excellence
Pharmalys was pleased to participate in TCIS Africa 2025, an important gathering of clinical research professionals from across the continent. The event underscored the progress being made in Africa’s research landscape, while also highlighting the essential work...
by milena henderson | May 19, 2025 | Non classé
Each year on 20 May, Clinical Trials Day marks the anniversary of James Lind’s pioneering scurvy trial in 1747. More than 275 years later, clinical trials remain one of the most powerful tools we have for improving health outcomes, generating evidence, and shaping the...
